Search results for "Lupus Erythematosu"

showing 10 items of 142 documents

Subcutaneous panniculitis-like T-cell lymphoma, lupus erythematosus profundus, and overlapping cases: molecular characterization through the study of…

2021

Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare cytotoxic cutaneous lymphoma. Differential diagnosis with lupus erythematosus panniculitis (LEP) can be challenging and overlapping cases have been described. In this study, we investigate whether gene expression profiling may or not identify markers that can be used to improve our understanding of the disease and to make a precise differential diagnosis. SPTCL, LEP, and overlapping cases were analyzed using a customized NanoString platform including 208 genes related to T-cell differentiation, stromal signatures, oncogenes, and tumor suppressor genes. Gene expression unsupervised analysis of the samples differentiated SPTCL f…

Cancer ResearchPathologymedicine.medical_specialtyPanniculitiseducationBiologyLymphoma T-CellCutaneous lymphomaDiagnosis Differential03 medical and health sciences0302 clinical medicineSubcutaneous Panniculitis-Like T-Cell LymphomaPanniculitis Lupus ErythematosusmedicineHumansT-cell lymphomahealth care economics and organizationsLupus erythematosusHematologymedicine.diseaseImmunohistochemistryLymphomaGene expression profilingOncology030220 oncology & carcinogenesisDifferential diagnosishormones hormone substitutes and hormone antagonistsLupus erythematosus panniculitis030215 immunologyLeukemia & Lymphoma
researchProduct

Early Vascular Aging in Normotensive Patients With Systemic Lupus Erythematosus

2015

Connective tissue diseases, like systemic lupus erythematosus (SLE), are associated with early and accelerated atherosclerosis. Recently, the concept of “early vascular aging” (EVA) has been more widely accepted. Aortic stiffness is one of the important markers of EVA. We evaluated EVA and subclinical atherosclerosis, by measuring aortic pulse wave velocity (aPWV) and carotid intima–media thickness (cIMT), in 50 normotensive patients with SLE (mean age: 39 ± 12 years). We compared these participants with 50 age- and sex-matched patients with essential hypertension (EH) and 20 healthy controls. Each participant underwent 24-hour ambulatory blood pressure monitoring (ABPM), aPWV, and cIMT me…

Carotid Artery DiseasesMaleSettore MED/09 - Medicina InternaSLEBlood Pressure030204 cardiovascular system & hematologyEssential hypertensionCarotid Intima-Media Thickness0302 clinical medicineRisk FactorsLupus Erythematosus SystemicUltrasonography Doppler Colorskin and connective tissue diseasesPulse wave velocityAge FactorsBlood Pressure Monitoring AmbulatoryMiddle Agedcardiovascular systemCardiologyFemaleVascular agingAortic stiffnessEssential HypertensionCardiology and Cardiovascular MedicineAdultmedicine.medical_specialtyAmbulatory blood pressurePulse Wave AnalysisRenal Circulation03 medical and health sciencesVascular StiffnessInternal medicinemedicineHumansIn patientSettore MED/14 - Nefrologia030203 arthritis & rheumatologyAccelerated atherosclerosisbusiness.industryAtherosclerosismedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareSettore MED/16 - ReumatologiaCase-Control StudiesSubclinical atherosclerosisAsymptomatic DiseasesVASCULAR DAMAGEAORTIC STIFFFNESSEARLY VASCULAR AGINGVascular ResistancebusinessAngiology
researchProduct

The fungal lactone oxacyclododecindione is a potential new therapeutic substance in the treatment of lupus-associated kidney disease.

2013

Recently oxacyclododecindione (Oxa), a macrocyclic lactone isolated from the imperfect fungus Exserohilum rostratum, has been described as a potent transcription inhibitor of inducible proinflammatory and profibrotic genes in cell culture models. As kidney disease in systemic lupus erythematosus is characterized by aberrant expression of inflammatory mediators and infiltration of immune cells, we investigated the effect of Oxa in MRL-Fas(lpr) mice, a model of systemic lupus erythematosus. These mice develop a spontaneous T-cell and macrophage-dependent autoimmune disease including severe glomerulonephritis that shares features with human lupus. Comparable to the results of in vitro models, …

ChemokineMice Inbred MRL lprMacrocyclic CompoundsAnti-Inflammatory AgentsProtein Array AnalysisGene ExpressionInflammationChemokine CXCL9Proinflammatory cytokineInterferon-gammaMiceImmune systemmedicineAnimalsCalgranulin ARNA MessengerChemokine CCL4Chemokine CCL5Chemokine CCL2Autoimmune diseaseSystemic lupus erythematosusbiologyInterleukin-6Tumor Necrosis Factor-alphaGlomerulonephritismedicine.diseaseLupus NephritisChemokine CXCL12Disease Models AnimalNephrologyImmunologybiology.proteinCytokinesFemaleOsteopontinmedicine.symptomKidney diseaseKidney international
researchProduct

PS7:145 Il-34, not csf-1, similarly mediates rheumatoid and lupus arthritis in patients

2018

While Myeloid cells are abundant in lupus arthritis (LA) and rheumatoid arthritis (RA), based on clinical presentation LA and RA are considered distinct diseases. Although inflammatory arthritis is common in patients with lupus, the pivotal mechanisms leading to joint damage have not been investigated. We tested the hypothesis that IL-34, but not CSF-1, is a predictive biomarker that is integral in perpetuating synovial destructive inflammation in both LA and RA. We report the novel findings that: using longitudinally tracked patients, IL–34, not CSF–1, is a clinical predictive biomarker for both LA and RA; and IL–34 is more robustly expressed in the synovial tissue, cells and fluid compare…

ChemokineSystemic lupus erythematosusbiologybusiness.industryInflammatory arthritisArthritisInflammationmedicine.diseaseSynovial CellRheumatoid arthritisImmunologymedicinebiology.proteinBiomarker (medicine)medicine.symptombusinessPoster session 7: New drugs and trageted therapy
researchProduct

Novel biosensor-based analytic device for the detection of anti-double-stranded DNA antibodies.

2007

AbstractBackground: Patients with systemic lupus erythematosus (SLE) develop a wide variety of serologic manifestations, including double-stranded DNA autoantibodies (anti-dsDNA). The determination of the potentially pathogenic autoantibodies is diagnostically relevant.Methods: We developed a novel surface plasmon resonance (SPR) biosensor chip for studies of dsDNA and anti-dsDNA binding. A synthetic oligonucleotide was coupled to biotinylated human transferrin, hybridized with the complementary antistrand, and ligated with a human recombinant dsDNA fragment 233 bp in length. After surface immobilization of this antigenic construct, diluted sera from SLE patients and healthy donors were ana…

Clinical BiochemistryPilot ProjectsBiosensing TechniquesBiologySensitivity and Specificitylaw.inventionchemistry.chemical_compoundAntigenimmune system diseaseslawHumansLupus Erythematosus SystemicSurface plasmon resonanceskin and connective tissue diseasesOligonucleotideBiochemistry (medical)DNASurface Plasmon ResonanceMolecular biologyReceptor–ligand kineticschemistryBiotinylationAntibodies AntinuclearRecombinant DNABiosensorDNAClinical chemistry
researchProduct

Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus.

1988

We investigated the connection between the C1q solid-phase binding assay (C1q SPBA) and double-stranded DNA antibodies, and analyzed the immune complex material in systemic lupus erythematosus (SLE) sera. Comparison with a new monoclonal assay for C1q-bearing immune complexes (the 242G3 assay) revealed that the immune complexes in SLE bind specifically to solid-phase C1q, and not to fluid-phase C1q. The C1q solid-phase binding activity sedimented as 7S IgG, was insensitive to DNase treatment, and could be selectively absorbed by C1q-coupled beads and by bovine serum albumin-anti-bovine serum albumin C1q beads, but not by DNA. Thus, antibodies to double-stranded DNA do not interfere in the C…

Complement Activating EnzymesImmunologySerum albuminchemical and pharmacologic phenomenaEnzyme-Linked Immunosorbent AssayAntigen-Antibody Complexurologic and male genital diseasesfluids and secretionsImmune systemRheumatologyimmune system diseasesComplement C1medicineImmunology and AllergyHumansLupus Erythematosus SystemicPharmacology (medical)Bovine serum albuminskin and connective tissue diseasesAutoantibodiesLupus erythematosusbiologybusiness.industryLigand binding assayComplement C1qAutoantibodyDNA Neoplasmmedicine.diseaseImmune complexImmunoglobulin GImmunologybiology.proteinCollagenAntibodybusinessUltracentrifugationArthritis and rheumatism
researchProduct

Cytotoxic effects of antibodies to proteinase 3 (C-ANCA) on human endothelial cells.

1994

SUMMARY Autoantibodies directed against cytoplasmic antigens of neutrophils (ANCA), especially those with specificity for proteinase 3 (PR-3) and myeloperoxidase, are valuable markers for differential diagnosis and monitoring of disease activity in Wegener's granulomatosis (WG) and other vasculitides. Till now, several concepts concerning a direct role of antibodies against PR-3 in the pathogenesis of WG have been discussed. Recently we were able to show that these antibodies recognize PR-3 translocated into the membrane of human endothelial cells. The aim of this study was to investigate putative cytotoxic effects of antibodies to PR-3 on human endothelial cells. Antibodies were obtained b…

Cytotoxicity ImmunologicC-ANCAEndotheliumMyeloblastinImmunologyAutoantigensChromatography AffinityAntibodies Antineutrophil CytoplasmicAntigenProteinase 3medicineImmunology and AllergyCytotoxic T cellHumansLupus Erythematosus SystemicCells CulturedAutoantibodiesMixed Connective Tissue DiseasebiologySerine EndopeptidasesAntibody-Dependent Cell CytotoxicityGranulomatosis with PolyangiitisEndothelial stem cellmedicine.anatomical_structureSjogren's SyndromeMyeloperoxidaseImmunologybiology.proteinEndothelium VascularAntibodyResearch ArticleClinical and experimental immunology
researchProduct

Parvovirus B19 nonstructural protein-induced damage of cellular DNA and resultant apoptosis.

2010

Parvovirus B19 is a widespread virus with diverse clinical presentations. The viral nonstructural protein, NS1, binds to and cleaves the viral genome, and induces apoptosis when transfected into nonpermissive cells, such as hepatocytes. We hypothesized that the cytotoxicity of NS1 in such cells results from chromosomal DNA damage caused by the DNA-nicking and DNA-attaching activities of NS1. Upon testing this hypothesis, we found that NS1 covalently binds to cellular DNA and is modified by PARP, an enzyme involved in repairing single-stranded DNA nicks. We furthermore discovered that the DNA nick repair pathway initiated by poly(ADPribose)polymerase and the DNA repair pathways initiated by …

DNA RepairDNA damageViral nonstructural proteinDNA repairPoly ADP ribose polymerasevirusesBlotting WesternParvovirus B19Viral Nonstructural ProteinsCell Linechemistry.chemical_compoundsystemic lupus erythematosusParvovirus B19 HumanHumansImmunoprecipitationPolymerasebiologyfulminant liver failureDNA damage and repairapoptosisvirus diseasesGeneral MedicineTransfectionMolecular biologyProliferating cell nuclear antigenchemistrybiology.proteinDNAautoantibodyDNA DamageResearch PaperInternational journal of medical sciences
researchProduct

Influence of molecular weight of DNA on the determination of anti-DNA antibodies in systemic lupus erythematosus (SLE) sera by radioimmunoassay

1975

Using a radioimmunoassay (RIA) based on the Farr technique with radioactively labeled 3-H-DNA for quantitative measurements of anti-DNA antibodies in sera of patients with systemic lupus erythematosus (SLE), the influence of molecular weight of DNA (ranging from 0.1 times 10-6 to 22.0 times 10-6 daltons) on binding and precipitation in this system has been investigated. Comparing our results with mathematical models it follows that one antibody molecule is fixed on the average to a statistical DNA segment of 2 times 10-6 to 4 times 10-6 daltons. Furthermore binding capacity of the DNA was found to be independent of the molecular weight, as demonstrated in a double label experiment using 14-…

DNA BacterialRadioimmunoassayBiologyModels BiologicalAntibodieschemistry.chemical_compoundGeneticsmedicineChemical PrecipitationLupus Erythematosus SystemicBinding siteAnti dnaLupus erythematosusMolecular massRadioimmunoassayDNAmedicine.diseaseMolecular biologyMolecular WeightAntibody moleculechemistryBiochemistrybiology.proteinBinding Sites AntibodyAntibodyDNANucleic Acids Research
researchProduct

Immunomodulatory drugs: Oral and systemic adverse effects

2013

Objectives: The main objectives are to present the different adverses effects of the immunomodulatory drugs that can impair the quality of life of the immunosupressed patients and study the impact of immunomodualtion on oral diseases. Immunomodulatory drugs have changed the treatment protocols of many diseases where immune functions play a central role, such as rheumatic diseases. Their effect on oral health has not been systematically investigated, however. Study Design: We review current data on the new immunomodulatory drugs from the oral health perspective based on open literature search of the topic. Results: These target specific drugs appear to have less drug interactions than earlie…

DrugPathologymedicine.medical_specialtymedia_common.quotation_subjectPlacebo-controlled studyOdontologíaReviewBioinformaticsInflammatory bowel diseaselaw.inventionImmune systemRandomized controlled triallawmedicineHumansImmunologic FactorsAdverse effectGeneral Dentistrymedia_commonOral Medicine and PathologyLupus erythematosusbusiness.industry:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseCiencias de la saludstomatognathic diseasesOtorhinolaryngologyRheumatoid arthritisUNESCO::CIENCIAS MÉDICASSurgeryMouth DiseasesbusinessMedicina Oral Patología Oral y Cirugia Bucal
researchProduct